Peter L Jones, PhD

MyFSHD

MyFSHD is about education and personal empowerment for the worldwide facioscapulohumeral muscular dystrophy (FSHD) community. Here we have discussions and commentary hosted by FSHD researcher Peter Jones, PhD, on many things of interest to the FSHD community. Learn about the science behind the different FSHD therapeutic approaches, FSHD pathology, family genetics and FSHD diagnostics. We will discuss upcoming clinical trials and what to look forward to. You will get to understand how you can be better prepared, become involved, and help contribute to defeating FSHD once and for all.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: myfshd.org

Autor

Peter L Jones, PhD

Kategoria

Business

Strona podcastu

myfshd.org

Ostatni odcinek

9 lis 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android 10 mln+ pobrań · ocena 4,7+ iOS wkrótce

Odcinki

What's going on in FSHD, week ending April 30, 2022 30.04.2022

Dr. Jones answers some of your questions from the week and reviews recent advances in science that relate to FSHD

We investigate and help you understand the science behind myostatin inhibition (ACE-083 trial) and berberine supplementation for FSHD; effective in the lab, not so much in you. 27.04.2022

Drs. Peter and Takako Jones discuss the ACE-083 trial and the basis of myostatin inhibition for FSHD, and go through the data showing that berberine, despite proof-of-concept studies showing it to be an inhibitor of DUX4 expression, is highly unlikely to be an effective treatment for FSHD.

What's going on in FSHD, week ending April 23, 2022. 23.04.2022

Dr. Peter Jones catches you up on the week in FSHD.

Some nutrition and exercise options for improving FSHD muscle health 20.04.2022

"Sonny, true love IS the greatest thing in the world -- except for a nice MLT - mutton, lettuce and tomato sandwich, where the mutton is nice and lean and the tomato is ripe."  Dr. Mark Tarnopolsky, the Director of the Neuromuscular and Neurometabolic Clinic at McMaster University in Hamilton, Ontario, Canada, sits down with Priscilla Sharun and Peter Jones to talk about how diet, certain sup...

What's going on in FSHD, week ending April 16th 16.04.2022

Peter Jones recaps the week in FSHD; Solve FSHD, CRISPR, Morgan Hoffmann.

Questions and comments from "Dad" about the future of FSHD 13.04.2022

Peter Jones sits down with a true stakeholder in all of this and talks curing FSHD. Brad Hasenjaeger is a concerned father and husband who wants action.

What's going on in FSHD week ending April 9th, 2022 09.04.2022

Dr. Peter Jones gives a brief recap of the week and answers some questions from patients.

Chip Wilson discusses his new venture, Solve FSHD, and his vision for restoring muscle health in FSHD and aging. 06.04.2022

Chip Wilson, founder of Lululemon and an FSHD patient, sits down with Drs. Peter Jones and Charis Himeda to discuss his new $100 million venture, Solve FSHD, aimed at curing FSHD and age-related muscle decline.

What's going on in FSHD, week ending April 2 02.04.2022

Peter Jones answers recent patient questions and addresses issues relating to FSHD

The making of a FSHD mouse 30.03.2022

Drs. Takako and Peter Jones discuss how they made the FLExDUX4 FSHD-like mouse model that is used around the world for FSHD therapeutic development and preclinical testing.

What's going on in FSHD March 26th 2022 26.03.2022

Free flowing commentary on all things FSHD

FSHD researcher Dr. Julie Dumonceaux talks FSHD with MyFSHD UK Ambassador Kate Fowles 24.03.2022

Dr. Julie Dumonceaux, Professor at University College London Great Ormond Street Institute of Child Health in London, England, discusses her lab's FSHD work and overall FSHD efforts in the UK with MyFSHD UK Ambassador Kate Fowles.

FSHD therapeutics overview 17.03.2022

Dr. Charis Himeda joins us again to talk all types of FSHD therapeutic approaches

Epigenetics and FSHD 12.03.2022

A primer on epigenetic gene and genome regulation and how it relates to FSHD

The DUX4 story with Dr. Alexandra Belayew 10.03.2022

Dr. Alexandra Belayew from the University of Mons in Belgium and the discoverer of DUX4 sits down with volunteer MyFSHD Ambassador Jenny Hasenjaeger to discuss the discovery of DUX4, the Fulcrum Losmapimod trial, antisense, and a little bit of everything FSHD.

FSHD1, FSHD2, & FSHD1+2 basics 06.03.2022

A short primer on the genetic differences and similarities between FSHD1, FSHD2, and FSHD1+2 just to make sure we are all up to speed.

CRISPR technology for FSHD with Dr. Charis Himeda 02.03.2022

Dr. Peter Jones sits down with Dr. Charis Himeda to discuss her invention of CRISPR-inhibition for FSHD, some of the bumps along the way, and its ultimate therapeutic potential and constraints.  In addition, other CRISPR technology that is being developed for FSHD is discussed.

FSHD diagnostics explained 27.02.2022

Dr Peter Jones explains genetic diagnostics for FSHD1 and FSHD2.  This covers various methods for FSHD deletion testing through the new epigenetic research testing, and the difference between CLIA-approved testing and research testing.  The final 20 minutes takes you through your FSHD genetic report if you participated in the epigenetic research testing at the Jones Lab at UNR.

MyFSHD Rare Disease Day with Dr. Ryan Wuebbles, FSHD patient and neuromuscular disease researcher. 25.02.2022

Dr. Peter Jones sits down with Dr. Ryan Wuebbles to discuss his journey with FSHD first as a patient and now as a researcher.  Covers some FSHD basics, research approaches, and how you can be the best advocate for FSHD.

Słuchaj podcastu MyFSHD w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS